These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Seeking effectiveness in health care: the federal perspective. Roper WL Internist; 1990 Jan; 31(1):9-10. PubMed ID: 10103664 [TBL] [Abstract][Full Text] [Related]
43. Information overload? As genetic testing kits sold directly to consumers gain popularity, medical professionals and lawmakers wonder if more regulation is needed. Goodwin K State Legis; 2008 Sep; 34(8):30-3. PubMed ID: 18754160 [No Abstract] [Full Text] [Related]
44. Genetics, crime, and individual rights. Walters R Forum Appl Res Public Policy; 1993; 8(3):16-7. PubMed ID: 11652659 [No Abstract] [Full Text] [Related]
45. Donna Shalala's health care vision. Firshein J Faulkner Grays Med Health; 1993 Mar; 47(10):3-4. PubMed ID: 10124092 [No Abstract] [Full Text] [Related]
46. Science and regulation. Regulating direct-to-consumer personal genome testing. McGuire AL; Evans BJ; Caulfield T; Burke W Science; 2010 Oct; 330(6001):181-2. PubMed ID: 20929761 [No Abstract] [Full Text] [Related]
47. Federal budget helps drive health policy. A close-up look at the budget process and how it affects health care funding. Benjamin GC Physician Exec; 2001; 27(4):61-2. PubMed ID: 11481897 [TBL] [Abstract][Full Text] [Related]
49. Touring the health bureaucracy. Saudek CD Forum Med; 1980 Apr; 3(4):284-8. PubMed ID: 10246183 [No Abstract] [Full Text] [Related]
50. Coding for change: the power of the human genome to transform the American Health Insurance System. Geetter JS Am J Law Med; 2002; 28(1):1-76. PubMed ID: 12025537 [No Abstract] [Full Text] [Related]
51. Genetic testing: should you pay? Dutton G Bus Health; 1996 Apr; 14(4):41, 43, 46. PubMed ID: 10157680 [No Abstract] [Full Text] [Related]
52. Health care talk unseemly when United States is at war. Levin-Epstein M Manag Care; 2001 Nov; 10(11):18-20. PubMed ID: 11761586 [No Abstract] [Full Text] [Related]
53. Health policy report. The Reagan record on health care. Iglehart JK N Engl J Med; 1983 Jan; 308(4):232-6. PubMed ID: 6336827 [No Abstract] [Full Text] [Related]
54. Underlying ambiguities in genetic privacy legislation. White MT Genet Test; 1999; 3(4):341-5. PubMed ID: 10627941 [TBL] [Abstract][Full Text] [Related]
55. Genetic profiteering. De Francesco L Nat Biotechnol; 2006 Aug; 24(8):888-90. PubMed ID: 16900119 [No Abstract] [Full Text] [Related]
56. Genetic testing. Terry SF Genet Test; 2008 Jun; 12(2):175-6. PubMed ID: 18554161 [No Abstract] [Full Text] [Related]
57. Reports on the potential dangers of genetic tests sold direct to the public. Human Genetics Commission Hum Reprod Genet Ethics; 2003; 9(2):21-2. PubMed ID: 14964207 [No Abstract] [Full Text] [Related]
58. Genetic testing and the future of disability insurance: ethics, law & policy. Wolf SM; Kahn JP; J Law Med Ethics; 2007; 35(2 Suppl):6-32. PubMed ID: 17543053 [TBL] [Abstract][Full Text] [Related]
59. Good genes. Are we ready for inexpensive, easy access to personal DNA tests? Rochman B Time; 2012 Aug; 180(8):14. PubMed ID: 22950259 [No Abstract] [Full Text] [Related]
60. "First, do no harm" will guide reform. Interview by Richard L. Clarke. Horner C Healthc Financ Manage; 1991 Aug; 45(8):18-22. PubMed ID: 10145469 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]